Journal
BIOLOGICAL PSYCHIATRY
Volume 49, Issue 3, Pages 258-267Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0006-3223(00)01094-5
Keywords
nicotine; attention; AD; memory; ADHD; cognition
Categories
Funding
- NIDA NIH HHS [DA 11943] Funding Source: Medline
Ask authors/readers for more resources
Nicotine and other nicotinic agonists have been found to improve performance on attention and memory tasks. Clinical studies using nicotine skin patches have demonstrated the efficacy of nicotine in treating cognitive impairments associated with Alzheimer's disease, schizophrenia, and attention-deficit/hyperactivity disorder. Experimental animal studies have demonstrated the persistence of nicotine-induced working memory improvement with chronic exposure, in addition to the efficacy of a variety of nicotinic agonists. Mechanistic studies have found that alpha7 and alpha4 beta2 nicotinic receptors in the hippocampus are critical for nicotinic involvement in cognitive function. Clinical and experimental animal studies provide mutually supporting information for the development of novel nicotinic therapies for cognitive dysfunction. (C) 2001 Society of Biological Psychiatry.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available